Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China-Reference-Cited by-同舟云学术

Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China

Published:2022-01-10 Issue:3 Volume:20 Page:417-429
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Xiao Jianhong^ORCID,Wu Yihui,Wang Min,Ma Zegang

Funder

the national social science foundation of china

marine “boutique tourism” innovative team project of shandong province

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40258-021-00706-9.pdf

Reference54 articles.

1. World Health Organization: SARS-CoV-2 Variants. (2020). https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON305. Accessed 6 Jun 2021.

2. World Health Organization: WHO Coronavirus (COVID-19) Dashboard. (2021). https://covid19.who.int/. Accessed 6 Jun 2021.

3. National Health Commission of the People’s Republic of China: Information Disclosure. (2021). http://www.nhc.gov.cn/xcs/yqtb/202106/c8576813374d4238bf7ec7f29ce75bbe.shtml. Accessed 6 Jun 2021.

4. Zhang L, Liu YH. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92(5):479–90. https://doi.org/10.1002/jmv.25707.

5. National Health Commission of the People’s Republic of China: News (2021). http://www.gov.cn/xinwen/2021-01/10/content_5578578.htm. Accessed 26 Aug 2021.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the willingness to invest returns among green, sustainability, and blue bonds;Journal of Environmental Management;2024-07

2. Are retail investors willing to buy green bonds? A case for Japan;Journal of Sustainable Finance & Investment;2024-05-10

3. Parents’ willingness to pay for their children’s COVID-19 vaccine in Taiwan, China: A cross-sectional study;Human Vaccines & Immunotherapeutics;2023-01-02